ReNeuron Group announce recruitment for new Chief Executive

UK-based stem cell therapy company ReNeuron Group (AIM: RENE.L) has announced the recruitment for a new Chief Executive Officer.

The current CEO, Michael Hunt, will remain in that role until a suitable candidate has been recruited, following which he will remain on the Board of Directors in the new role of Chief Financial Officer, with responsibilities covering finance, public & investor relations and overall commercial and financial strategy.

Following the significant recent progress the company has made, the Board, including Mr Hunt, has concluded that the executive leadership should be expanded to best manage the multiple opportunities now available to the Company.